Sinovac Biotech : Supplemental Submission Pursuant to Item 1

Supplemental Submission Pursuant to Item 16I of Form 20-F


Sinovac Biotech Ltd. is submitting via EDGAR the following information as required under Item 16I of Form 20-F in... | May 1, 2023

Related Keywords

China , Weidong , Anhui , , Share Ownership Of The Company , Globe Capital , Exchange Commission , Sinovac Biotech Ltd , Public Company Accounting Oversight Board , Holding Foreign Companies Accountable , Supplemental Submission Pursuant , Holding Foreign Companies Accountable Act , Commission Identified Issuer , Grant Thornton , Weidong Yin , Prime Success , Vivo Capital , Exchange Shares , Senior Management , Sinovac Biotech Ltd Stock Exchange , News , Information , Press Release , Supplemental , Submission , Ursuant , O , Item , 6i , F , Form , Sinovac , Biotech , Us , Submitting , Cia , Dgar , The , Following , Equired , Under , Orm Sva Agp8696w1045 ,